Modulation of antitumor immunity--immunobiologic approaches.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D001500:BCG Vaccine / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004731:Endotoxins / Q000627:therapeutic use; D005354:Fibrosarcoma / Q000276:immunology / Q000628:therapy; D006023:Glycoproteins / Q000378:metabolism / Q000627:therapeutic use; D006168:Guinea Pigs; D006649:Histocompatibility Antigens / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007167:Immunotherapy; D008113:Liver Neoplasms; D012515:Mast-Cell Sarcoma / Q000628:therapy; D051379:Mice; D009336:Necrosis; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D011425:Propionibacterium acnes / Q000276:immunology; D011828:Radiation Chimera; D012513:Sarcoma, Experimental / Q000276:immunology / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000637:transplantation; D014409:Tumor Necrosis Factor-alpha
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D004731:Endotoxins; D006023:Glycoproteins; D006649:Histocompatibility Antigens; D014409:Tumor Necrosis Factor-alpha; C029237:tumor-associated transplantation antigen